Equally aligned with previous results, BiP expression was found to be higher in metastatic tumors, with its nuclear expression being associated with higher a tumor stage and poorer outcome, further suggesting, that BiP could be a prognostic indicator for breast cancer. Here, HSPA5 is linked to breast carcinoma.